Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a processed pseudogene related to ribosomal protein L18a. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they usually arise from gene duplications or retrotransposition and have lost their protein-coding ability or are otherwise no longer expressed in the cell. The parent gene, RPL18A, encodes a component of the 60S ribosomal subunit, which is involved in cytoplasmic protein synthesis, but the pseudogene does not contribute to ribosome formation or function[1][3][7]. Multiple RPL18A pseudogenes, such as RPL18AP1, RPL18AP5, RPL18AP8, and others, are scattered across the human genome and have no known protein-coding function[2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L18a pseudogene.